Oral cyclophosphamide in relapsed ovarian cancer: a tertiary centre experience over 5 years.

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Myrto Kastrisiou, Aymen Amasayb, Susana N. Banerjee, Angela Joy George, Narda Kebaier Ep Chaabouni
DOI: 10.1016/j.ijgc.2025.103800
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103800–103800
Publication date
1 February 2026
Language
EN